Latest

neuropharmacology

This shows a picture of a brain with lightening

·March 15, 2021·3 min read

Adding Omega-3 Based Medication to Statins May Lower Stroke Risk

Adding icosapent ethyl, a triglyceride-lowering medication that is high in the omega 3 fatty acid, eicosapentaenoic acid, in combination with statins helped to reduce stroke risk by 36% in those with cardiovascular disease.

This is a spiky psychedelic star which becomes an optical illusion the longer you look at it

Featured Neuroscience Open Neuroscience Articles Psychology

·March 10, 2021·7 min read

Psychedelic Science Holds Promise for Mainstream Medicine

A new study investigates psychedelic medicine on brain activity and the potential for using psychedelics to treat a range of disorders.

Featured Genetics Neurology Neuroscience

·March 9, 2021·6 min read

CBD Reduces Plaque and Improves Cognition in Model of Familial Alzheimer’s

A two-week course of CBD helps normalize and restore the function of two proteins associated with reducing amyloid-beta accumulation in mouse models of familial Alzheimer's disease. CBD also reduces levels of IL-6, an immune protein associated with inflammation in Alzheimer's patients.

Featured Neurology Neuroscience Open Neuroscience Articles

·March 4, 2021·5 min read

AI Helps With Drug Repurposing for Alzheimer’s

Researchers have developed a new artificial intelligence algorithm designed to examine existing drugs as potential Alzheimer's treatments.

Featured Neurology Neuroscience

·March 4, 2021·5 min read

Smoking Cessation Drug May Treat Parkinson’s in Women

A smoking cessation drug called cytisine may be a helpful new tool for the treatment of Parkinson's disease in women. Cytisine was found to reduce the loss of dopamine neurons. The effect was more pronounced when estrogen was present.

This shows a sad looking man looking out of a window at the rain

Featured Neuroscience Psychology

·March 3, 2021·6 min read

Researchers Identify Brain Ion Channel as New Approach to Treating Depression

Ezogabine, a drug that opens up the KCNQ2/3 type potassium channel, significantly improved symptoms of depression and anhedonia.

Featured Neurology Neuroscience

·March 3, 2021·4 min read

Sesame Seed Shell Byproduct Sesaminol is a Parkinson’s Disease’s Surprise Medicine

Sesaminol, a chemical byproduct of sesame seed shells, has neuroprotective properties against Parkinson's disease.

Featured Neurology Neuroscience

·March 3, 2021·3 min read

Drug Target Could Fight Parkinson’s and Alzheimer’s Disease

The SARM1 protein triggers a cascade of degeneration associated with Alzheimer's, Parkinson's, and other neurodegenerative diseases. Researchers hope new drugs can be developed to directly target this protein to fight neurodegeneration.

Featured Neurology Neuroscience

·March 2, 2021·3 min read

Potential Drug for Alzheimer’s Disease Prevention Found Safe and Effective in Animals

A new drug modulates, rather than inhibits, a key enzyme implicated in the formation of Alzheimer's related plaques.

This shows a man holding his head in pain

Featured Neurology Neuroscience Pain

·March 1, 2021·2 min read

Can Cannabis Use Lead to Rebound Headaches for People With Migraine?

People who use cannabis to help manage the pain associated with chronic migraine are six times more likely to suffer from rebound headaches, or medication overuse headaches, than those who do not use marijuana.

Featured Neurology Neuroscience

·February 26, 2021·4 min read

A New Substance to Suppress Neuroinflammation

Hymecromone, a commonly prescribed spasmolytic medication, is able to suppress immune response in astrocytes in the central nervous system.

Featured Neurology Neuroscience

·February 23, 2021·4 min read

Beta Blockers Can Repair Malformed Blood Vessels in the Brain

Propranolol, a beta-blocker commonly used to treat haemangioma in children and cardiovascular disease, can also be used to treat cerebral cavernous malformations, a condition characterized by misshapen neural blood vessels.